bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012

09-Nov-2010 - bioMérieux and Biocartis announced that they have entered into a strategic agreement to co-develop assays on Biocartis’ fully integrated molecular diagnostics system, which the two companies will co-distribute starting in 2012. Under the agreement, bioMérieux will have worldwide exclusive rights ...

Exonhit to Acquire Redpath Integrated Pathology, Inc.

Complementary fit between RedPath’s DNA platform and ExonHit’s RNA platform

27-Apr-2010 - ExonHit Therapeutics S.A. announced that it entered into a binding agreement for the acquisition of RedPath Integrated Pathology, Inc., a privately held molecular diagnostics company, focused on cancer. RedPath will become part of ExonHit’s US operations. Headquartered in Pittsburgh, ...

QIAGEN Acquires DxS Ltd

24-Sep-2009 - QIAGEN N.V. announced that it has acquired DxS Ltd (DxS), a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, United Kingdom. The transaction is valued at approximately US$ 95 million in cash (subject to customary purchase price adjustments), ...

Beckman Coulter Announces the Creation of Beckman Coulter Genomics

New Company Offers Comprehensive Genomic Services

17-Aug-2009 - Beckman Coulter, Inc. announced the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities. "Through the creation of Beckman Coulter ...

Fluxion Biosciences Signs New Distributor for Benelux and Scandinavia

Westburg BV to Distribute BioFlux Line of Live Cell Imaging Products

04-Dec-2008 - Fluxion Biosciences announced an exclusive distribution agreement with The Netherlands-based Westburg BV. Westburg BV will handle sales and service of Fluxion's BioFlux research tools for live cell image analysis in Belgium, The Netherlands, Luxembourg, Denmark, Finland, Iceland, Norway and ...

bioMerieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx

15-Sep-2008 - bioMérieux has acquired the privately held AviaraDx, Inc., a molecular in vitro diagnostics company, based in San Diego, California (USA). AviaraDx’s diagnostic tests, based on their proprietary technologies, are used in the molecular classification of cancers and to assist oncologists in making ...

QIAGEN and BioHelix Enter Into Licensing Agreement

Helicase-dependent isothermal DNA amplification system provides new assay technology capabilities for QIAGEN's assay automation platforms

05-May-2008 - QIAGEN and privately held BioHelix have announced that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's proprietary Helicase Dependent Amplification technology (HDA). HDA is a versatile assay technology to detect and analyze biological target molecules ...

Illumina Announces Corporate Reorganization

08-Jan-2008 - Illumina, Inc. announced that it has reorganized its operating structure to further leverage the synergies between its sequencing and genotyping businesses. Under the new structure, a newly created Life Sciences Business Unit will include all products and services related to the research market ...

QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products

Assay development centre for Singapore will support QIAGEN in the market for molecular testing solutions

05-Dec-2007 - QIAGEN and Bio*One Capital announced that they have entered into a joint venture to establish Dx Assays Pte Ltd ("Dx Assays"). Dx Assays expects to be one of the first centres in Singapore for assay development in which molecular diagnostics for infectious and genetic diseases will be developed. ...

QIAGEN Signs Agreement for the Acquisition of eGene

Strategic Transaction adds Capillary Sample Separation Technology Targeting Molecular Diagnostics and Other Applications

17-Apr-2007 - QIAGEN N.V. announced, that its subsidiary QIAGEN North American Holdings, Inc. has signed a definitive merger agreement with eGene, Inc. pursuant to which eGene would become a fully owned subsidiary of QIAGEN North American Holdings, Inc. eGene is an early-stage company, that has developed and ...